Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Clinical trial NCT06314906 · RECRUITING

Trial details

NCT number: NCT06314906
Sponsor: Feixue Song
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Electroacupuncture Olanzapine-contained Four-drug Antiemetic Nausea and Vomiting

Start date: 2024-03-07
Primary completion: 2027-01-31
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.